Return to search results.
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer (EPOCH)
Complete title: A Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
|Research Study Number||7627|
|Principal Investigator||William Harris|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Genders Eligible for Study: Both
- Colorectal cancer with metastases progressed after first line treatment
Other eligibility criteria may apply.
Exclusions (conditions that would prevent participation in this study)
- Contraindications to TheraSphere or second line chemotherapy
Other exclusion criteria may apply.
Colon Cancer; Rectal Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.